
LKFT
Healthcare · Biotechnology · $2.24B market cap
$33.98+0.05 (+0.1%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 10, 2026 | After the close | -11.50 | 0.03 | +100.3% |
| May 7, 2026 | Time not confirmed | -0.97 | 0.21 | +121.6% |
| Mar 26, 2026 | After the close | -0.07 | 12.27 | +17628.6% |
| Nov 5, 2025 | After the close | -0.28 | -0.18 | +35.7% |
| Jul 23, 2025 | After the close | -0.13 | -0.93 | -615.4% |
| Apr 23, 2025 | After the close | -0.18 | 0.97 | +638.9% |
| Feb 13, 2025 | Time not confirmed | — | 0.41 | — |
| Oct 30, 2024 | After the close | -0.12 | -0.74 | -516.7% |
| Aug 1, 2024 | After the close | -0.02 | 0.07 | +450.0% |
| May 2, 2024 | After the close | -0.13 | 0.36 | +376.9% |
| Nov 2, 2023 | After the close | -0.85 | 0.39 | +145.9% |
| Aug 3, 2023 | After the close | -0.37 | 0.08 | +121.6% |
| May 4, 2023 | After the close | -0.39 | 0.35 |
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in…
| +189.7% |
| Feb 24, 2023 | Time not confirmed | — | -3.21 | — |
| Nov 3, 2022 | After the close | -1.24 | -0.54 | +56.5% |
| Aug 4, 2022 | After the close | -0.22 | -0.29 | -31.8% |
| May 6, 2022 | Time not confirmed | — | -0.23 | — |
| Feb 23, 2022 | After the close | -1.14 | 0.57 | +150.0% |
| Nov 4, 2021 | After the close | -1.23 | -0.98 | +20.3% |
| Aug 5, 2021 | After the close | -1.00 | -0.99 | +1.0% |
| May 6, 2021 | After the close | -0.96 | -0.23 | +76.0% |
| Feb 18, 2021 | After the close | -0.81 | -0.84 | -3.7% |
| Nov 5, 2020 | After the close | -0.85 | -1.45 | -70.6% |
| Aug 6, 2020 | After the close | -0.93 | -1.75 | -88.2% |
| May 8, 2020 | Time not confirmed | — | -0.86 | — |
| Mar 27, 2020 | After the close | -0.72 | -1.39 | -93.1% |
| Oct 24, 2019 | After the close | 2.47 | 8.13 | +229.1% |
| Jul 25, 2019 | After the close | -0.96 | -0.87 | +9.4% |
| Apr 25, 2019 | After the close | -1.09 | -0.89 | +18.3% |
| Feb 22, 2019 | Time not confirmed | — | 0.31 | — |
| Oct 25, 2018 | After the close | -1.00 | 0.28 | +128.0% |
| Aug 3, 2018 | Before the open | -0.84 | -0.42 | +50.0% |
| Apr 25, 2018 | After the close | -0.91 | -0.73 | +19.8% |
| Feb 23, 2018 | Time not confirmed | — | -0.69 | — |